U.S. markets closed
  • S&P Futures

    3,928.00
    +5.50 (+0.14%)
     
  • Dow Futures

    31,995.00
    +79.00 (+0.25%)
     
  • Nasdaq Futures

    13,311.00
    +9.00 (+0.07%)
     
  • Russell 2000 Futures

    2,296.60
    +11.50 (+0.50%)
     
  • Crude Oil

    63.40
    +0.18 (+0.28%)
     
  • Gold

    1,795.50
    -2.40 (-0.13%)
     
  • Silver

    28.06
    +0.20 (+0.70%)
     
  • EUR/USD

    1.2165
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.3890
    +0.0270 (+1.98%)
     
  • Vix

    21.34
    -1.77 (-7.66%)
     
  • GBP/USD

    1.4138
    -0.0003 (-0.02%)
     
  • USD/JPY

    106.0300
    +0.1480 (+0.14%)
     
  • BTC-USD

    50,599.84
    +165.23 (+0.33%)
     
  • CMC Crypto 200

    1,009.95
    -4.96 (-0.49%)
     
  • FTSE 100

    6,658.97
    +33.03 (+0.50%)
     
  • Nikkei 225

    30,156.48
    +484.78 (+1.63%)
     

Drugmaker Merck divests stake in vaccine-maker Moderna

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

(Reuters) - U.S. drugmaker Merck & Co said on Wednesday it has sold its equity investment in Moderna Inc, after benefiting from a surge in the stock price of the vaccine developer this year.

Merck did not disclose the details of the sale proceeds, but said it expects to record a small gain from the sale in the fourth quarter of 2020. (https://bit.ly/3og5kil)

Moderna's shares have risen more than seven-fold this year, valuing the company at $55.80 billion as of Tuesday's closing price.

Moderna is one of the front-runners in the race to develop a coronavirus vaccine, and on Monday filed for U.S. emergency use authorization of its vaccine.

Merck, which had invested $50 million in Moderna in 2015, said it would retain exposure to the company indirectly through its investment in venture funds.

(Reporting by Manas Mishra in Bengaluru; Editing by Anil D'Silva and Shinjini Ganguli)